The Mosaic Company (MOS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
7 Jan, 2026Executive summary
Q4 2024 net income was $169 million and adjusted EBITDA was $594 million; full-year net income was $622 million and adjusted EBITDA $2.2 billion, with consolidated Q4 revenues of $2.8 billion and full-year revenues of $11.1 billion.
Segment performance was mixed: Potash and Mosaic Fertilizantes saw year-over-year declines in adjusted EBITDA, while Phosphate improved.
Strategic progress included asset sales, redeploying capital, and operational improvements, with a $522 million gain from the Ma'aden transaction.
Cost savings initiatives achieved about half of the $150 million target, with further improvements expected.
Returned $506 million to shareholders in 2024 through share repurchases and dividends.
Financial highlights
Q4 2024 Potash sales volumes were 2.239 million mt, with MOP selling price at $199/mt; Phosphate sales volumes were 1.622 million mt, DAP price $593/mt.
Mosaic Fertilizantes Q4 2024 sales volumes were 2.240 million mt, with average finished product price at $486/mt.
Adjusted diluted EPS for Q4 2024 was $0.45; for the full year, $1.98.
Gross margin rate for 2024 was 14%, down from 16% in 2023.
$522 million gain from Ma'aden transaction and $642 million FX loss in 2024.
Outlook and guidance
2025 phosphate production guidance: 7.2–7.6 million tonnes; potash: 8.7–9.1 million tonnes.
Q1 2025 phosphate sales volumes expected at 1.5–1.7 million tonnes, DAP prices $595–$615/tonne; potash sales 2.0–2.2 million tonnes, MOP prices $200–$220/tonne.
2025 capital expenditures projected at $1.2–$1.3 billion, with cost savings run rate target of $150 million expected by year-end.
Market outlook for 2025 is positive, with strong crop prices and tight fertilizer markets.
Adjusted effective tax rate projected in the high 20% range for Q1 and mid-to-high 20% for 2025.
Latest events from The Mosaic Company
- 2025 net income reached $541M; asset sales and cost gains set up stronger 2026 cash flow.MOS
Q4 202525 Feb 2026 - Targeting 55% EBITDA growth by 2030 via efficiency, digitalization, and biosciences.MOS
Investor Day 20253 Feb 2026 - Q2 2024 net loss driven by FX and price headwinds, but cost savings and capital returns advanced.MOS
Q2 20242 Feb 2026 - Q3 net income reached $122M on strong phosphate margins and robust capital returns.MOS
Q3 202414 Jan 2026 - Board independence, pay-for-performance, and ESG integration drive governance and strategy.MOS
Proxy Filing1 Dec 2025 - Annual Meeting to vote on directors, auditor, and executive pay, with board support for all.MOS
Proxy Filing1 Dec 2025 - Q2 2025 delivered strong earnings, margin growth, and raised production guidance.MOS
Q2 202523 Nov 2025 - Q1 2025 net income hit $238M as margins rose, costs fell, and global demand stayed strong.MOS
Q1 202518 Nov 2025 - Q3 2025 delivered strong earnings, higher sales, and robust Brazil and potash performance.MOS
Q3 20258 Nov 2025